SRDX•benzinga•
Looking Into Surmodics's Return On Capital Employed
Summary
Surmodics (NASDAQ:SRDX) brought in sales totaling $26.11 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 45.2%, resulting in a loss of $4.08 million.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 2, 2022 by benzinga